Plaintiffs 'second guessing' how pro-competitive Effexor XR deal could have been, Wyeth says (*corrects)
Plaintiffs suing Wyeth and Teva over their agreement involving generic versions of the drug Effexor XR are improperly arguing that the deal between the companies is unlawful because it could have...To view the full article, register now.
Already a subscriber? Click here to view full article